Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord exosomes for bronchopulmonary dysplasia in premature infants
IRCT20241122063802N5Phase 2Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2025
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of umbilical cord-derived exosomes in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Pulmonary function and severity of BPD at 3 months, Mechanical ventilation cases and complications related to BPD and 3 more. Started Nov 2025; status: recruiting.
02
Drugs
umbilical cord-derived exosomes
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20241122063802N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241122063802N5.